Carlisle Companies Incorporated Quick Ratio (CSL) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Carlisle Companies Incorporated  (NYSE: CSL)

Carlisle Companies Incorporated's Quick Ratio

CSL's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2026, Quick Ratio deteriorated to 0.62 below Carlisle Companies Incorporated's average Quick Ratio.

Within Medical Equipment & Supplies industry 125 other companies have achieved higher Quick Ratio than Carlisle Companies Incorporated in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 1590 to 2229.

Explain Quick Ratio?
How much Cash & cash equivalents CSL´s has?
What are CSL´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CSL/financial-strength
https://api.csimarket.com/api/v1/companies/CSL/fundamentals
https://api.csimarket.com/api/v1/companies/CSL/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
CSL Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 15.12 %
Y / Y Cash & cash equivalent Change -50.52 %
Quick Ratio MRQ 0.62
CSL's Total Ranking # 2229
Seq. Current Liabilities Change -0.91 %
Seq. Cash & cash equivalent Change -17.83 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 126
Healthcare Sector # 685
Overall Market # 2229


Quick Ratio Statistics
High Average Low
2.83 0.9 0.1
(Mar 31 2015)   (Jun 30 2025)




Financial Statements
Carlisle Companies Incorporated's Current Liabilities $ 880 Millions Visit CSL's Balance sheet
Carlisle Companies Incorporated's Cash & cash equivalent $ 547 Millions Visit CSL's Balance sheet
Source of CSL's Sales Visit CSL's Sales by Geography


Cumulative Carlisle Companies Incorporated's Quick Ratio

CSL's Quick Ratio for the trailling 12 Months

CSL Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 32.44 %
Y / Y Cash & cash equivalent TTM Growth 44.17 %
Quick Ratio TTM 0.86
Total Ranking TTM # 3920
Seq. Current Liabilities TTM Growth 3.31 %
Seq. Cash & cash equivalent TTM Growth -15.28 %


On the trailing twelve months basis Due to decrease in Current Liabilities in the Q3 2026 to $880.30 millions, cumulative Quick Ratio decreased to 0.86 above the CSL average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 200 other companies have achieved higher Quick Ratio than Carlisle Companies Incorporated. While Quick Ratio overall ranking has improved so far to 3920, from total ranking during the twelve months ending second quarter 2026 at 3986.

Explain Quick Ratio?
How much Cash & cash equivalents CSL´s has?
What are CSL´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 201
Healthcare Sector # 891
Within the Market # 3920


trailing twelve months Quick Ratio Statistics
High Average Low
1.9 0.55 0.06
(Sep 30 2014)   (Sep 30 2022)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Anika Therapeutics Inc   1.68 $ 44.957  Millions$ 26.725  Millions
EBR Systems, Inc.  1.63 $ 85.415  Millions$ 52.539  Millions
Intuitive Surgical Inc   1.60 $ 4,042.500  Millions$ 2,533.000  Millions
Tactile Systems Technology Inc   1.58 $ 75.110  Millions$ 47.499  Millions
Edap Tms Sa  1.56 $ 56.269  Millions$ 36.070  Millions
Neuraxis Inc   1.55 $ 4.477  Millions$ 2.888  Millions
Envista Holdings Corporation  1.42 $ 1,158.800  Millions$ 816.300  Millions
Inogen Inc   1.38 $ 96.840  Millions$ 70.265  Millions
Intelligent Bio Solutions Inc   1.30 $ 5.930  Millions$ 4.578  Millions
Si bone inc   1.20 $ 35.460  Millions$ 29.619  Millions
Medline Inc   1.12 $ 3,608.000  Millions$ 3,211.000  Millions
Pro dex Inc   1.10 $ 14.219  Millions$ 12.884  Millions
Penumbra Inc  1.09 $ 254.282  Millions$ 233.810  Millions
Koru Medical Systems Inc   1.08 $ 7.364  Millions$ 6.792  Millions
Establishment Labs Holdings Inc   1.06 $ 75.812  Millions$ 71.611  Millions
Globus Medical Inc   1.02 $ 517.435  Millions$ 507.938  Millions
Envoy Medical Inc   0.98 $ 14.570  Millions$ 14.861  Millions
Integra Lifesciences Holdings Corp  0.95 $ 311.930  Millions$ 329.002  Millions
Myomo Inc   0.93 $ 11.946  Millions$ 12.902  Millions
Strata Critical Medical Inc   0.92 $ 41.641  Millions$ 45.118  Millions
Haemonetics Corporation  0.87 $ 260.712  Millions$ 300.838  Millions
Treace Medical Concepts Inc   0.86 $ 39.798  Millions$ 46.079  Millions
Innovage Holding Corp   0.85 $ 162.993  Millions$ 192.479  Millions
Lifestance Health Group Inc   0.84 $ 218.818  Millions$ 261.129  Millions
Neuronetics Inc   0.82 $ 22.106  Millions$ 26.856  Millions
Orthopediatrics Corp  0.80 $ 44.229  Millions$ 55.632  Millions
Livanova Plc  0.76 $ 563.467  Millions$ 740.193  Millions
West Pharmaceutical Services Inc   0.72 $ 464.100  Millions$ 644.300  Millions
Resmed Inc   0.72 $ 1,010.742  Millions$ 1,406.488  Millions
Electrocore Inc   0.69 $ 7.506  Millions$ 10.866  Millions

Date modified: 2026-10-30T16:59:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.